These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37564199)

  • 1. Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade.
    Lv J; Wu Q; Li K; Bai K; Yu H; Zhuang J; Sun H; Yang H; Yang X; Lu Q
    Int J Biol Sci; 2023; 19(12):3744-3761. PubMed ID: 37564199
    [No Abstract]   [Full Text] [Related]  

  • 2. HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway.
    Lv J; Li K; Yu H; Han J; Zhuang J; Yu R; Cheng Y; Song Q; Bai K; Cao Q; Yang H; Yang X; Lu Q
    J Exp Clin Cancer Res; 2023 Feb; 42(1):41. PubMed ID: 36747239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated Fibroblast-derived Extracellular Vesicles Mediate Immune Escape of Bladder Cancer via PD-L1/PD-1 Expression.
    Feng R; Li Z; Ge G; Wang C; Jia Y; Ouyang J
    Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1410-1420. PubMed ID: 36852791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3/YTHDF2 m
    Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
    J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation.
    Yu Y; Liang Y; Xie F; Zhang Z; Zhang P; Zhao X; Zhang Z; Liang Z; Li D; Wang L; Chen Y; Sun L; Niu H; Wang Y
    Cancer Lett; 2024 Jul; 593():216964. PubMed ID: 38762193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
    Wang QM; Lian GY; Song Y; Huang YF; Gong Y
    Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of SETD7 promotes migration and invasion of lung cancer cells via JAK2/STAT3 pathway.
    Cao L; Ren Y; Guo X; Wang L; Zhang Q; Li X; Wu X; Meng Z; Xu K
    Int J Mol Med; 2020 May; 45(5):1616-1626. PubMed ID: 32323737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of multi-omics and clinical treatment data reveals bladder cancer therapeutic vulnerability gene combinations and prognostic risks.
    Xu Y; Sun X; Liu G; Li H; Yu M; Zhu Y
    Front Immunol; 2023; 14():1301157. PubMed ID: 38299148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer.
    Zhang J; Zhou Q; Xie K; Cheng L; Peng S; Xie R; Liu L; Zhang Y; Dong W; Han J; Huang M; Chen Y; Lin T; Huang J; Chen X
    J Exp Clin Cancer Res; 2021 Jun; 40(1):203. PubMed ID: 34154613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircZNF609 inhibited bladder cancer immunotherapy sensitivity via enhancing fatty acid uptake through IGF2BP2/CD36 pathway.
    Li K; Lv J; Wang J; Wei Y; Zhang Y; Lin J; Zhu Q
    Int Immunopharmacol; 2024 Aug; 137():112485. PubMed ID: 38878487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SETD7 Promotes Cell Proliferation and Migration via Methylation-mediated TAF7 in Clear Cell Renal Cell Carcinoma.
    Zhang J; Duan B; Li F; Jing X; Li R; Cai S; Cao L; Jiang Q; Zhou J; Zhou J; Qin Y; Wang X; Tong D; Huang C
    Int J Biol Sci; 2024; 20(8):3008-3027. PubMed ID: 38904013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
    PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of SET domain containing lysine methyltransferase 7 in tumorigenesis and development.
    Yang S; Wang X; Bai J; Duan B
    Cell Cycle; 2023 Feb; 22(3):269-275. PubMed ID: 36101480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen Receptor Transcriptionally Inhibits Programmed Death Ligand-1 Expression and Influences Immune Escape in Bladder Cancer.
    Sun A; Luo Y; Xiao W; Zhu Z; Yan H; Miao C; Zhang W; Bai P; Liu C; Yang D; Shao Z; Song J; Wu Z; Chen B; Xing J; Wang T
    Lab Invest; 2023 Jul; 103(7):100148. PubMed ID: 37059268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion.
    Lu C; Paschall AV; Shi H; Savage N; Waller JL; Sabbatini ME; Oberlies NH; Pearce C; Liu K
    J Natl Cancer Inst; 2017 Jan; 109(6):. PubMed ID: 28131992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SETD7 promotes metastasis of triple-negative breast cancer by YY1 lysine methylation.
    Gao L; Zhang J; Long Q; Yang Y; Li Y; Li G; Pu P; Tong S; He Y; Li Q; Chen Y; Liu Y; Kong X
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166780. PubMed ID: 37286143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KCNQ1OT1 sponges miR-34a to promote malignant progression of malignant melanoma via upregulation of the STAT3/PD-L1 axis.
    Wang X; Ren Z; Xu Y; Gao X; Huang H; Zhu F
    Environ Toxicol; 2023 Feb; 38(2):368-380. PubMed ID: 36399467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demethylase JMJD2D induces PD-L1 expression to promote colorectal cancer immune escape by enhancing IFNGR1-STAT3-IRF1 signaling.
    Chen Q; Zhuang S; Hong Y; Yang L; Guo P; Mo P; Peng K; Li W; Xiao N; Yu C
    Oncogene; 2022 Mar; 41(10):1421-1433. PubMed ID: 35027670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression.
    Chen Z; Chen X; Xie R; Huang M; Dong W; Han J; Zhang J; Zhou Q; Li H; Huang J; Lin T
    Mol Ther; 2019 Feb; 27(2):326-341. PubMed ID: 30660488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.